We are live on ! Find out more
KXA

KPCB XV Associates Portfolio holdings

AUM $35.8M
1-Year Est. Return 57.59%
This Fund
S&P 500
This Quarter Est. Return
-26.22%
1 Year Est. Return
-57.59%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$54.2M
AUM Growth
-$23.1M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 70.62%
2 Technology 29.38%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPT
1
DELISTED
RAPT Therapeutics
RAPT
$23.7M 43.66%
162,133
– –
TWLO icon
2
Twilio
TWLO
$29.8B
$15.9M 29.38%
190,047
– –
ATRA icon
3
Atara Biotherapeutics
ATRA
$77.8M
$14.6M 26.96%
75,066
– –
AUGX
4
DELISTED
Augmedix, Inc. Common Stock
AUGX
$1K ﹤0.01%
708
– –

Similar funds

ALFIA
Accel Leaders Fund II Associates Palo Alto, California $36.6M AUM 58.14% 1-Year Est. Return
KCGDR
Kiron Capital Gestao de Recursos Sao Paulo, Brazil $36.9M AUM 49.85% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
SEM
Spectrum Equity Management San Francisco, California $39.1M AUM 63.69% 1-Year Est. Return
MCMI
Matrix China Management III Grand Cayman, Cayman Islands $39.3M AUM
LCM
LH Capital Markets New York $39.4M AUM 14.61% 1-Year Est. Return

KPCB XV Associates's Q2 2022 Portfolio in Review

As of Q2 2022, KPCB XV Associates held 4 positions worth $54.2M, down 30% from $77.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. KPCB XV Associates opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 59% a quarter earlier, followed by Technology and Industrials.

  • KPCB XV Associates's ten largest holdings make up 100% of its $54.2M portfolio in Q2 2022.
  • KPCB XV Associates opened 0 new positions and closed 0 in Q2 2022.
  • KPCB XV Associates's portfolio value fell 30% quarter-over-quarter to $54.2M.

Based on KPCB XV Associates's 13F filing for Q2 2022, filed 21 Jul 2022.